Omeprazolo Ranbaxy Italia (Omeprazole)

Omeprazolo Ranbaxy Italia is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑oesophageal reflux disease (GERD): alleviates symptoms and promotes healing of the oesophageal lining.
• Peptic ulcer disease (PUD): supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.
• Erosive oesophagitis: heals erosive damage to the oesophagus.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

• Omeprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this pump, it blocks the final step of acid production, leading to a sustained increase in gastric pH and reduction of gastric acidity.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: increased intestinal gas.
• Constipation: occasional bowel habit change.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis risk.
• Acute interstitial nephritis: renal inflammation.
• Hypomagnesemia: low serum magnesium levels.
• Stevens‑Johnson syndrome: severe skin reaction.
• Liver enzyme elevation: potential hepatic impact.
• Fracture risk: possible decreased bone density with long‑term use.

When prescribing Omeprazolo Ranbaxy Italia, clinicians should consider several safety aspects:

• Assess renal function: adjust use in severe impairment.
• Evaluate hepatic function: use with caution in liver disease.
• Review long‑term therapy: monitor for bone density loss.
• Consider infection risk: be alert for Clostridioides difficile symptoms.
• Pregnancy and lactation: weigh benefits against potential risks.
• Store at below 25°C: keep in the original packaging, protect from moisture and light.

Omeprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect.
• Atazanavir: decreased antiviral absorption.
• Methotrexate: increased serum concentration.

Moderate Interactions (Monitor Closely)

• Warfarin: potential INR elevation.
• Phenytoin: altered plasma levels.
• Digoxin: possible increase in serum concentration.